Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease

BACKGROUND: Indoleamine 2,3 dioxygenase (IDO), the rate-limiting enzyme in the kynurenine (Kyn) pathway of tryptophan (Trp) degradation, is modulated by inflammation, and is regarded as a key molecule driving immunotolerance and immunosuppressive mechanisms. Little is known about IDO activity in pat...

詳細記述

保存先:
書誌詳細
出版年:BMC Cardiovasc Disord
主要な著者: Wongpraparut, Nattawut, Pengchata, Ploy, Piyophirapong, Sudarat, Panchavinnin, Pariya, Pongakasira, Rungtiwa, Arechep, Noppadol, Kasetsinsombat, Kanda, Maneechotesuwan, Kittipong
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314527/
https://ncbi.nlm.nih.gov/pubmed/34311709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-021-02140-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料